Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

M.D. Anderson Cancer Center to guide arglabin preclinical studies

Jan. 18, 2000

Matrix completes patient enrollment in pivotal head and neck cancer trials

Jan. 17, 2000

Nippon Kayaku devotes significant resources to the fight against cancer

Jan. 17, 2000

Porphyrin-based agents for PDT and MRI designed at Schering AG

Jan. 17, 2000

Kinase-inhibitory antiproliferative indolones in development at Boehringer Ingelheim

Jan. 17, 2000

Mechanism of MDR reversal by TER-199 under investigation

Jan. 14, 2000

Access files IND for amlexanox oral rinse

Jan. 14, 2000

ImClone Systems achieves milestone in IMC-C225 collaboration with Merck KGaA

Jan. 13, 2000

Cephalon's CEP-701 enters phase II trials in prostate cancer

Jan. 13, 2000

FDA to review Aptosyn NDA without ODAC input

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...